4
Changes in Ownership
Lineage Cell Therapeutics, Inc. Filed Acc 0001493152-24-009382
Options or other derivatives
- President and CEO acquired 1,900,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Culley Brian M President and CEO | 2024-03-07 | Grant or award · Employee Stock Option (Right to Buy) | +1,900,000 | 1,900,000 | D: show line 1 in the form |
Loading xslF345X05/ownership.xml…